IVONNE REYES: Open Payments
NPI 1164997086 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 40 payments from 11 companies in 2025. Trend: 2023 $353 · 2024 $612 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $196 |
| Novo Nordisk Inc | 5 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| ABBVIE INC. | 3 | $64 |
| Lilly USA, LLC | 2 | $52 |
| Edwards Lifesciences Corporation | 1 | $45 |
| Almatica Pharma LLC | 2 | $40 |
| Exact Sciences Corporation | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: OTEZLA, Wegovy, MOUNJARO, FARXIGA, EVENITY, SAPIEN 3 Ultra RESILIA, LOREEV XR, VRAYLAR.
Industry payments across CA — which companies pay providers there.
